Bayer Names Pfizer’s Brandicourt Healthcare Division CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
The broadly experienced pharmaceutical executive – who has specialized particularly in emerging markets and infectious diseases – inherits a healthcare division that is in the midst of several product launches and has few near-term patent expirees.